Dr Alistair Reid is a consultant Clinical Scientist in the CPA-accredited Imperial Molecular Pathology Laboratories. He also holds a HEFCE-NIHR Senior Lecturership in the Centre for Haematology at Imperial College.
He has an active laboratory-based translational research program and is mentor to 3 Ph.D. students. His main research interests are the genomic and transcriptomic heterogeneity of chronic myeloid leukaemia and novel methods for the personalised genetic management of malignancy.
Dr Reid lectures on cancer genetics to BSc, MBBS and MSc students and offers a limited number of research projects for BSc and MSc students.
et al., 2016, Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients, Journal of Molecular Diagnostics, Vol:18, ISSN:1525-1578, Pages:176-189
et al., 2016, Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy, Leukemia, Vol:30, ISSN:0887-6924, Pages:2275-2279
et al., 2015, PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase, American Journal of Hematology, Vol:90, ISSN:0361-8609, Pages:20-26
Tosi S, Reid AG, 2016, The Genetic Basis of Haematological Cancers, John Wiley & Sons, ISBN:9781118528051